MANHATTAN ASSOCIATES INC
Manhattan Associates (MANH) stock hit a 52-week high at $220.61, up 59% in six months. The company reported strong Q2 2026 earnings, beating estimates with $1.39 EPS on $297.8M revenue. Analysts raised price targets to $225 (Stifel) and $240 (Truist), citing cloud business growth. The stock has a P/E ratio of 61.92 and is considered overvalued by InvestingPro.
After July PPI came in flat m/m and CPI rose 0.1% m/m with annual inflation cooling to 3.4%, investors priced in a less aggressive Fed stance, lifting software and data stocks. Wix rose 5.5% (to $73.57), AppLovin 1.9%, Manhattan Associates 0.4%, Strategy 0.6%, and Oracle 0.8%.
Clark Eric Andrew (President & CEO) sold 3,000 shares of MANHATTAN ASSOCIATES INC (MANH) at $197.76 ($0.59M total) on 2026-08-11.
Over the past 7 days, alphai's AI scored 1 news story mentioning MANH (MANHATTAN ASSOCIATES INC). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent MANH coverage spans earnings, insider activity and macro economy.
In the last 30 days, MANH insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($1.9M). The most active reporter was Hollembaek Linda T. with 1 filing.
Strong earnings and raised guidance may drive the stock higher.
Price action is framed as sector beta to rates, with no incremental MANH catalyst provided.
Routine insider sale with no 10b5-1 plan disclosed; it may slightly affect sentiment but is not a fundamental change.
A director open-market sale reduces insider exposure but does not, by itself, signal a fundamental change.
The piece frames MANH as short-term momentum plus new 2026 guidance, but valuation models diverge sharply, creating a near-term narrative-driven trading setup.
alphai scores every news story that mentions MANH with an AI model for sentiment and relevance, and aggregates insider trades from MANHATTAN ASSOCIATES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Manhattan Associates (MANH) stock hit a 52-week high at $220.61, up 59% in six months. The company reported strong Q2 2026 earnings, beating estimates with $1.39 EPS on $297.8M revenue. Analysts raised price targets to $225 (Stifel) and $240 (Truist), citing cloud business growth. The stock has a P/E ratio of 61.92 and is considered overvalued by InvestingPro.
2 min readAfter July PPI came in flat m/m and CPI rose 0.1% m/m with annual inflation cooling to 3.4%, investors priced in a less aggressive Fed stance, lifting software and data stocks. Wix rose 5.5% (to $73.57), AppLovin 1.9%, Manhattan Associates 0.4%, Strategy 0.6%, and Oracle 0.8%.
4 min readClark Eric Andrew (President & CEO) sold 3,000 shares of MANHATTAN ASSOCIATES INC (MANH) at $197.76 ($0.59M total) on 2026-08-11.
1 min readHollembaek Linda T. sold 1,579 shares of MANHATTAN ASSOCIATES INC (MANH) at $189.88 ($0.30M total) on 2026-08-06.
1 min readSimply Wall St says Manhattan Associates (MANH) is back in focus after a “golden cross” and new 2026 earnings guidance. The article cites the stock at $195.23, with 30-day return 26.04% and 90-day return 41.75%, while 1-year total shareholder return fell 5.13%. It estimates fair value at $153.03 versus a DCF cash-flow value of about $267.79.
6 min readGantt James Stewart (EVP, Professional Services) sold 5,139 shares of MANHATTAN ASSOCIATES INC (MANH) at $195.53 ($1.00M total) on 2026-07-30.
1 min readManhattan Associates (NASDAQ: MANH) shares rose 22.6% after the company reported Q2 2026 adjusted earnings of $1.39 per share on $297.8 million revenue, beating analyst estimates. The firm raised full-year revenue guidance to a $1.16 billion midpoint and lifted adjusted EPS guidance to $5.47 at the midpoint.
4 min readManhattan Associates (MAnhattan Associates) shares rose 26.7% to $213.07 after the company reported record Q2 results. Revenue was $297.8M, up 9.3% year over year and above consensus of about $293.7M. Cloud subscription revenue grew 26% to $126.7M. Non-GAAP EPS was $1.39 vs $1.34 expected. Remaining performance obligations rose 23% to $2.5B.
6 min readU.S. stocks opened lower amid rate-hike jitters and an upcoming tech earnings cycle. Investing.com listed major movers including KLA-Tencor (KLAC -8.07%), Applied Materials (AMAT -5.05%), and Arm (ARM -5.81%). Lennox (LII) fell about 8% after a Q2 revenue miss and reduced guidance, while Teva (TEVA) rose on a Q2 top-line beat.
4 min readManhattan Associates (MANH) reported second-quarter results that beat guidance. The company said revenue rose 9% year over year to $298 million, above guidance of $287 million. Non-GAAP operating margin was 34.9%, versus 34.7% guided.
2 min read
